Results 91 to 100 of about 276,656 (346)

FIB‐3 index as a novel age‐independent predictor of liver fibrosis and prognosis in hepatocellular carcinoma patients undergoing hepatectomy

Annals of Gastroenterological Surgery, EarlyView.
Fibrosis‐3 index (FIB‐3) can stratify the risk of the survival and the recurrence‐free survival. The FIB‐3 index is a reliable, age‐independent tool for assessing liver fibrosis and prognosis in HCC patients post‐hepatectomy. Its use may improve clinical outcomes and support personalized treatment strategies. Abstract Background Liver fibrosis is a key
Yuki Imaoka, Masahiro Ohira, Tsuyoshi Kobayashi, Naruhiko Honmyo, Michinori Hamaoka, Takashi Onoe, Daisuke Takei, Koichi Oishi, Tomoyuki Abe, Toshihiro Nakayama, Miho Akabane, Kazunari Sasaki, Hideki Ohdan, Hiroshima Surgical study group of Clinical Oncology (HiSCO)   +13 more
wiley   +1 more source

Liver transplantation for hepatitis C virus (HCV) non‐viremic recipients with HCV viremic donors

American Journal of Transplantation, 2018
In the context of organ shortage, the opioid epidemic, and effective direct‐acting antiviral (DAA) therapy for hepatitis C virus (HCV), more HCV‐infected donor organs may be used for liver transplantation.
A. Kwong, A. Wall, M. Melcher, U. Wang, Aijaz Ahmed, A. Subramanian, P. Kwo   +6 more
semanticscholar   +1 more source

Surgical and Oncological Outcomes of Conversion Surgery After Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Locally Advanced Hepatocellular Carcinoma

Annals of Gastroenterological Surgery, EarlyView.
Conversion surgery for HCC. ABSTRACT Background Since 2013, we have performed conversion surgery after hepatic arterial infusion chemotherapy (HAIC) for initially unresectable locally advanced hepatocellular carcinoma (LA‐HCC). Methods Between 2013 and 2021, we assessed the surgical and oncological outcomes and pathological findings of patients with LA‐
Yuichi Goto, Yutaro Mihara, Takashi Niizeki, Hisamune Sakai, Sachiko Ogasawara, Jun Akiba, Hirohisa Yano, Takumi Kawaguchi, Fumihiko Fujita, Toru Hisaka   +9 more
wiley   +1 more source

Strategies to induce broadly protective antibody responses to viral glycoproteins

Expert Review of Vaccines, 2017
Introduction: Currently, several universal/broadly protective influenza virus vaccine candidates are under development. Many of these vaccines are based on strategies to induce protective antibody responses against the surface glycoproteins of ...
F Krammer
doaj   +1 more source

Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan [PDF]

Clinical and Molecular Hepatology
Background/Aims Steatotic liver disease (SLD) is a common manifestation in chronic hepatitis C (CHC). Metabolic alterations in CHC are associated with metabolic dysfunction-associated steatotic liver disease (MASLD).
Chung-Feng Huang, Chia-Yen Dai, Yi-Hung Lin, Chih-Wen Wang, Tyng-Yuan Jang, Po-Cheng Liang, Tzu-Chun Lin, Pei-Chien Tsai, Yu-Ju Wei, Ming-Lun Yeh, Ming-Yen Hsieh, Chao-Kuan Huang, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu   +14 more
doaj   +1 more source

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

New England Journal of Medicine, 2014
BACKGROUND In clinical trials, treatment with a combination of the nucleotide polymerase inhibitor sofosbuvir and the antiviral drug ribavirin was associated with high response rates among patients with hepatitis C virus (HCV) genotype 2 infection, with ...
S. Zeuzem, G. Dusheiko, R. Salupere, A. Mangia, R. Flisiak, R. Hyland, A. Illeperuma, E. Svarovskaia, D. Brainard, W. Symonds, G. Subramanian, J. Mchutchison, O. Weiland, H. Reesink, P. Ferenci, C. Hézode, R. Esteban   +16 more
semanticscholar   +1 more source

Prognostic Impact of Hepatectomy Versus Radiofrequency Ablation for Non‐Small Hepatocellular Carcinoma (2–3 cm): A Case‐Matched Study

Annals of Gastroenterological Surgery, EarlyView.
This study aims to elucidate prognostic outcomes of hepatectomy versus RFA for primary 2–3 cm HCC. Hepatectomy may offer superior prognostic benefits, especially in those with elevated AFP levels. The local recurrence rate in hepatectomy is significantly lower than RFA.
Yuki Kitano, Hiromitsu Hayashi, Takumi Tanizaki, Yoshiyuki Tagayasu, Takashi Matsumoto, Rumi Itoyama, Shigeki Nakagawa, Hirohisa Okabe, Masaaki Iwatsuki   +8 more
wiley   +1 more source

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.

New England Journal of Medicine, 2015
BACKGROUND The combination of daclatasvir, a hepatitis C virus (HCV) NS5A inhibitor, and the NS5B inhibitor sofosbuvir has shown efficacy in patients with HCV monoinfection.
D. Wyles, P. Ruane, M. Sulkowski, D. Dieterich, A. Luetkemeyer, T. Morgan, K. Sherman, R. Dretler, D. Fishbein, J. Gathe, S. Henn, F. Hinestrosa, C. Huynh, Cheryl Mcdonald, A. Mills, E. Overton, M. Ramgopal, B. Rashbaum, G. Ray, A. Scarsella, J. Yozviak, F. Mcphee, Zhaohui Liu, E. Hughes, P. Yin, S. Noviello, Peter Ackerman   +26 more
semanticscholar   +1 more source

Multi‐Module Micro/Nanorobots for Biomedical and Environmental Remediation Applications

Advanced Intelligent Systems, EarlyView.
Multi‐module microrobots (MNRs) have overcome the limitations of single‐module systems by integrating components such as propeller, actuator, manipulator, and imaging modalities. They show promise in biomedical applications, such as targeted drug delivery and tissue repair, as well as in environmental remediation, including pollutant removal.
Bairong Zhu, Amar Salehi, Lei Xu, Wei Yuan, Tingting Yu   +4 more
wiley   +1 more source

Cryoglobulinemia and hepatitis C virus

Журнал инфектологии, 2014
The review presents recent data on cryoglobulinemiaassociated with a hepatitis C virus: prevalence, pathogenesis, clinical manifestations, laboratory diagnostics, approaches to therapy.
N. V. Dunaeva, E. V. Esaulenko
doaj   +1 more source